Skip to main content
logo
Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
3.435
-0.165 (-4.58%)
Oct 26, 2026, 12:12 PM EDT - Market open

Impact BioMedical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.040.03--0.05-
Revenue Growth
400.00%-----
Gross Profit
-0.39-0.39--0.05-
Operating Income
-5.1-4.27-3.4-4.03-3.4-3.19
Net Income
0.79-11.84-24.71-4.34-7.05-1.3
Earnings Per Share
0.07-4.80-29.03-0.91-1.26-0.23
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.0102000.05
Total Debt
--8.8812.079.9912.52
Net Cash (Debt)
0.010-6.88-12.07-9.99-12.48
Net Cash Growth
------
Net Cash Per Share
0.000.00-8.07-2.53-1.79-2.23

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.51-1.89-2.85-2.85-2.24-2.03
Capital Expenditures
----0.02-0.28-
Free Cash Flow
-0.51-1.89-2.85-2.87-2.52-2.03
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----100.00%-
Operating Margin
-14557.14%-13343.75%---6808.00%-
Pretax Margin
-5148.57%-45156.25%---15752.00%-
Profit Margin
2260.00%-36993.75%---14102.00%-
FCF Margin
-1451.43%-5906.25%---5036.00%-

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
878.791651.05----